P Libert
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 20
- Lung Cancer Research Studies 19
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 1
- Drug Transport and Resistance Mechanisms 1
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Jean‐Paul Sculier (15 shared papers)Gérard Bureau (20 shared papers)G Dabouis (16 shared papers)Jacques Thiriaux (19 shared papers)Jean A. Klastersky (22 shared papers)Marianne Paesmans (12 shared papers)J. Michel (8 shared papers)Oswald Van Cutsem (11 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Lung Cancer (4 papers)European Journal of Cancer (4 papers)Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- BelgiumFranceLuxembourg
In The Last Decade
P Libert
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 74
- Oncology 811
- Pulmonary and Respiratory Medicine 649
- Epidemiology 183
- Cancer Research 59
- Otorhinolaryngology 15
Countries citing papers authored by P Libert
This map shows the geographic impact of P Libert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Libert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Libert more than expected).
Fields of papers citing papers by P Libert
This network shows the impact of papers produced by P Libert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Libert. The network helps show where P Libert may publish in the future.
Co-authors
The 25 scholars most cited alongside P Libert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 355 | |
| 2 | 1990 | 213 | |
| 3 | 2000 | 197 | |
| 4 | 1986 | 126 | |
| 5 | 1989 | 118 | |
| 6 | 1997 | 76 | |
| 7 | 1993 | 69 | |
| 8 | 1990 | 53 | |
| 9 | 1994 | 30 | |
| 10 | Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party. | 1983 | 28 |
| 11 | 1990 | 26 | |
| 12 | 1990 | 25 | |
| 13 | 1992 | 19 | |
| 14 | 1977 | 18 | |
| 15 | 1990 | 15 | |
| 16 | 1990 | 14 | |
| 17 | 1987 | 13 | |
| 18 | 1988 | 10 | |
| 19 | 1994 | 7 | |
| 20 | 1994 | 5 |
About P Libert
P Libert is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Immunology and Allergy, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (19 papers), Lung Cancer Treatments and Mutations (13 papers), Neuroendocrine Tumor Research Advances (7 papers), Cancer therapeutics and mechanisms (5 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Oncology (811 citations), Pulmonary and Respiratory Medicine (649 citations), Epidemiology (183 citations), Cancer Research (59 citations) and Otorhinolaryngology (15 citations). P Libert has collaborated with scholars based in Belgium, France and Luxembourg. Frequent co-authors include Jean‐Paul Sculier, Gérard Bureau, G Dabouis, Jacques Thiriaux, Jean A. Klastersky, Marianne Paesmans, J. Michel, Oswald Van Cutsem, P. Mommen and ROGER SERGYSELS. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, European Journal of Cancer, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.